KRROKorro Bio Inc. Common Stock

13.18USD-5.52%Mkt Cap: 194.08M $P/E:

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United St…

Key Statistics

Company
Market Cap194.08M $
Enterprise Value118.02M $
Revenue (TTM)2.38M $
Gross Profit-41.02M $
Net Income (TTM)-117.26M $
Revenue/Share0.1980 USD
Last Price13.18 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees57
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-2.91
PEG
EV/EBITDA-1.59
EV/Revenue49.55
P/S80.12
P/B1.85
EPS (TTM)-9.19
EPS (Forward)-4.46
52W Range
5.20416% of range55.89
52W High55.89 USD
52W Low5.204 USD
Profitability
Gross Margin0.00%
Oper. Margin-3228.34%
EBITDA Margin0.00%
Profit Margin-1834.48%
ROE-227.96%
ROA-103.31%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-78.56M $
CapEx (TTM)518.00K $
FCF Margin-1737.62%
FCF Yield-21.33%
Net Debt-72.82M $
Net Debt/EBITDA0.98
Balance Sheet
Debt/Equity0.85
Current Ratio9.55
Quick Ratio9.11
Book Value/Sh7.019 USD
Cash/Share7.812 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:50
Split DateNov 6, 2023
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.20 USD
Upside (mean)+53.3%
Target Range10.00 USD30.00 USD
$10.00+53.3% to mean$30.00
# Analysts10
Ownership
Shares Out.14.73M
Float10.47M
Insiders0.94%
Institutions105.23%
Short Interest
Short Ratio7.6d
Short % Float10.96%
Short % Out.9.78%
Shares Short1.44M
Short (prev mo.)1.71M
Technical
SMA 5012.48 (+5.6%)
SMA 20011.97 (+10.1%)
Beta2.21
S&P 52W Chg18.16%
Avg Vol (30d)138.07K
Avg Vol (10d)91.90K
Technical Indicators
RSI (14)56.4
MACD0.3827
MACD Signal0.1760
MACD Hist.+0.2066
BB Upper14.69 USD
BB Middle12.01 USD
BB Lower9.330 USD
BB Width44.65%
ATR (14)0.8783 USD
Vol Ratio (20d)0.39x